Susan Longhofer
About Susan Longhofer
Susan Longhofer serves as the Chief Scientific Officer at Dechra Pharmaceuticals PLC, a position she has held since 2020. She earned her Master of Science in Veterinary Medicine from the University of Wisconsin-Madison and holds a BS and DVM from Texas A&M University.
Work at Dechra Pharmaceuticals
Susan Longhofer serves as the Chief Scientific Officer at Dechra Pharmaceuticals PLC. She has held this position since 2020, contributing to the company's mission in the veterinary pharmaceutical sector. Her role involves overseeing scientific research and development initiatives, ensuring that Dechra remains at the forefront of veterinary medicine. Based in the Kansas City, Missouri area, she plays a critical role in advancing the company's product offerings and enhancing its scientific capabilities.
Education and Expertise
Susan Longhofer has a strong educational background in veterinary medicine. She earned her Bachelor of Science and Doctor of Veterinary Medicine (DVM) degrees from Texas A&M University, completing her studies from 1976 to 1981. She furthered her education at the University of Wisconsin-Madison, where she achieved a Master of Science (MS) in Veterinary Medicine from 1986 to 1989. This extensive education has equipped her with the expertise necessary for her leadership role in the veterinary pharmaceutical industry.
Background
Susan Longhofer's professional journey in veterinary medicine spans several decades. Her foundational education in veterinary science laid the groundwork for her career. After completing her studies, she has dedicated her professional life to advancing veterinary medicine, culminating in her current role as Chief Scientific Officer at Dechra Pharmaceuticals. Her experience and academic background contribute to her understanding of the complexities within the field.
Achievements
Since joining Dechra Pharmaceuticals in 2020, Susan Longhofer has been instrumental in driving scientific initiatives within the company. Her leadership in research and development has helped to enhance the company's product pipeline. While specific achievements during her tenure are not detailed, her role as Chief Scientific Officer indicates a significant level of responsibility and influence in shaping the company's scientific direction.